Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

mAbxience and Biosidus Sign CDMO Agreement for the Manufacture of Agalsidase Beta for the Treatment of Fabry Disease

Published

on

mabxience-and-biosidus-sign-cdmo-agreement-for-the-manufacture-of-agalsidase-beta-for-the-treatment-of-fabry-disease

MADRID, Feb. 5, 2024 /PRNewswire/ — mAbxience, a leading company in the development and manufacture of biopharmaceutical products, and part of the Fresenius Kabi and Insud Pharma groups, has announced today an important agreement with Biosidus, a renowned Argentine company specialized in biotechnology. This agreement, focused in the area of CDMO (Contract Development and Manufacturing Organization), implies that mAbxience will be responsible for the manufacture of the active ingredient Agalsidase Beta, developed by Biosidus as a biosimilar of Fabrazyme.

The use of Agalsidase Beta is an innovative treatment for Fabry disease. This disease results from the total or partial deficiency of the lysosomal enzyme a-galactosidase A, which results in the pathological accumulation of glycosphingolipids in vascular walls, differentiated cells and fluids. Recent analyses of some international neonatal research results show a frequency of 1 in 22,570 males with classic forms and 1 in 1,390 in late forms, positioning it as the most frequent lysosomal deposit disease.

This agreement marks a significant milestone for both mAbxience and Biosidus, as it represents a strategic advance in their respective areas of expertise. In addition, mAbxience strengthens its position in the CDMO sector, demonstrating its ability to collaborate in the development and manufacture of complex, high-value treatments. For Biosidus, this agreement means a significant milestone in its path to increase its impact in the global pharmaceutical industry, being the first biosimilar molecule for the treatment of a rare disease developed in Latin America and emerging markets, reinforcing its commitment to innovation and access to high quality treatments at affordable prices hand in hand with a solid industrial partner such as mAbxience.

The agreement reinforces the vision of both companies to be leaders in the biopharmaceutical industry, combining the technical expertise and production capacity of mAbxience with the innovation and patient focus of Biosidus. This joint effort is expected to have a significant impact on the lives of patients affected by Fabry disease, providing access to essential treatments in Argentina and, subsequently, in other countries around the world.

 

View original content:https://www.prnewswire.co.uk/news-releases/mabxience-and-biosidus-sign-cdmo-agreement-for-the-manufacture-of-agalsidase-beta-for-the-treatment-of-fabry-disease-302051912.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

7th CIIE Successfully Wraps: Highlights by the Numbers

Published

on

7th-ciie-successfully-wraps:-highlights-by-the-numbers

SHANGHAI, Nov. 28, 2024 /PRNewswire/ — The 7th China International Import Expo (CIIE) drew to a successful close on November 10th in Shanghai. While many intangible achievements and connections were made, this year’s data shows how the Expo achieved unprecedented success in global participation and business opportunities. Tentative deals totaled USD 80.01 billion, marking a 2 percent increase from the previous year.

Vibrant Participation from around the World

As a crucial platform for global collaboration, the 7th CIIE invited 77 countries and international organizations from five continents for the Comprehensive Country Exhibition. Participants incorporated unique cultures, national identities, and modern technology into booth designs, with an impressive lineup of over 200 captivating events hosted at the booths. A total of 3,496 companies from 129 countries and regions participated in the Enterprise & Business Exhibition, including 1,585 companies from 104 countries in the Belt and Road Initiative, 1,106 companies from 13 countries in the Regional Comprehensive Economic Partnership, and 132 exhibitors from 35 least developed countries.

Wide Range of Cutting-Edge Innovations and Debuts

Innovative achievements and diverse debuts have consistently been a major highlight from each edition of the expo. At the 7th CIIE, the Innovation Incubation Special Section showcased 360 innovative projects from 34 countries and regions, supporting the development of small and medium-sized enterprises (SMEs) and startups. In addition, multinational companies introduced 450 new products, services, and technologies, including over 100 global launches, 40 Asia premieres, and over 200 China debuts, unlocking momentum for new drivers of consumer demand.

International Perspectives and Collaborative Dialogues at the HQF

Serving as an important platform for international communication, the Hongqiao International Economic Forum (HQF) becomes a focal point of attention at each edition of the CIIE. Focusing on trending topics, the 7th HQF attracted over 8,600 registrations and convened more than 300 globally renowned experts and leaders in politics, business, and academia. The 7th HQF also released the World Openness Report 2024 alongside the World Openness Index, delivering a message of openness and fostering international cooperation.

The 7th China International Import Expo was undoubtedly a complete success, demonstrating its significant role as a stage for advancing global cooperation. With preparations for the 8th CIIE actively underway, the expo continues to expand opportunities for global trade and economic cooperation, warmly inviting countries and enterprises from abroad to join!

Visit CIIE official website for more information: https://www.ciie.org/zbh/en/?from=prnewswire

Contact: Ms. Cui Tel.: 0086-21-968888 Email: [email protected]

Advertisement

Photo – https://mma.prnewswire.com/media/2569264/image_5031553_31815944.jpg

Continue Reading

Fintech PR

Europi Property Group AB (publ) successfully issues senior unsecured green bonds

Published

on

europi-property-group-ab-(publ)-successfully-issues-senior-unsecured-green-bonds

STOCKHOLM, Nov. 28, 2024 /PRNewswire/ —

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES TO DISTRIBUTE THIS ANNOUNCEMENT.

Europi Property Group AB (publ) (“Europi” or the “Company“) has successfully issued senior unsecured green bonds of EUR 50m under a framework of up to EUR 100m and a tenor of three years (the “Green Bonds“). The Green Bonds have a floating interest of 3M Euribor plus 500 basis points per annum. Europi intends to list the Green Bonds on the sustainable bond list of Nasdaq Stockholm within 12 months and Nasdaq Transfer Market within 60 days, with an ambition to have the Green Bonds admitted to trading within 30 days.

An amount corresponding to the net proceeds from the Green Bonds will be used in accordance with the Company’s green finance framework (the “Green Finance Framework“).

Skandinaviska Enskilda Banken AB (publ) and ABG Sundal Collier AB have acted as advisors in relation to the issue of the Green Bonds. Vinge has acted as legal counsel in relation to the issue of the Green Bonds.

More information regarding the Green Finance Framework and Sustainalytics’ second party opinion can be found at https://europi.se/bond-investors/

For further information, please contact: 
Jonathan Willén, CEO, [email protected]
+46 (0) 8 411 55 77

About Europi (www.europi.se)
Europi Property Group, founded in 2019, is a pan-European real estate investment company headquartered in Stockholm (with an office also in London) investing discretionary capital across all sectors with a flexible investment strategy. Europi has since inception completed public and private transactions of more than €700m in gross asset value alongside its established network of local operating partners and completed four successful exists. By combining a truly entrepreneurial, active ownership approach with focus on social and environmental sustainability, Europi generates long term value and positive impact for all stakeholders.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/europi-property-group/r/europi-property-group-ab–publ–successfully-issues-senior-unsecured-green-bonds,c4073222

Advertisement

View original content:https://www.prnewswire.co.uk/news-releases/europi-property-group-ab-publ-successfully-issues-senior-unsecured-green-bonds-302318389.html

Continue Reading

Fintech PR

Bybit x Block Scholes Derivatives Report: ETH Outperforms BTC

Published

on

bybit-x-block-scholes-derivatives-report:-eth-outperforms-btc

DUBAI, UAE, Nov. 28, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, in collaboration with Blocks Scholes, released the latest weekly derivatives analytics report and uncovered signals indicating ETH’s rise above BTC in the past week.

Fueled by news of current U.S. SEC Chair Gary Gensler’s departure at the end of the Biden administration’s term, ETH performance has positively surprised investors. In particular, open interest in ETH perpetual has been on the rise. Several large-cap altcoins also benefited from Gensler’s announcement, anticipating less scrutiny upcoming January.

Key Insights:

ETH outperformed BTC in open interest: Perpetual swap data has seen a gradual decline in BTC open interest while ETH contracts increased. ETH has also been taking a bigger share of daily trading volumes in the past 6-month time frame despite an overall slower market this week. The optimism could be attributed to hopeful investors’ expectation of a more crypto-friendly SEC Chair after Gensler’s last day on Jan. 20, 2025.

BTC price in retreat: BTC price’s ebbing from the $100K mark has flattened the ATM volatility term structure, with short-tenor options dipping below 60%. This mirrors a pattern observed since the U.S. election. Lower realized volatility explains the drop, while open interest in calls and puts remains unchanged, demands for short-term options this week have stagnated.

ETH options – bullish sentiment in moderation: ETH options show slightly more bullish sentiment than BTC options. Markets have recalibrated after the post-election high, but call options remain in the lead in both trading volumes and open interests.

Access the Full Report:

Read the full report in context here.

#Bybit / #TheCryptoArk /#BybitResearch

About Bybit

Advertisement

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving over 50 million users. Established in 2018, Bybit provides a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press

For media inquiries, please contact: [email protected]

For more information, please visit: https://www.bybit.com

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Bybit Logo

Photo – https://mma.prnewswire.com/media/2569395/Bybit_x_Block_Scholes_Derivatives_Report_ETH_Outperforms_BTC.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/bybit-x-block-scholes-derivatives-report-eth-outperforms-btc-302318387.html

Continue Reading

Trending